Tumor reduction by a small molecule human PD-1/PD-L1 inhibitor in a melanoma/PBMC co-implantation model.

被引：0

作者：

Vilalta, Marta ^{[1
]}

Punna, Sreenivas ^{[1
]}

Li, Shijie Chris ^{[1
]}

Malathong, Viengkham ^{[1
]}

Lange, Christopher ^{[1
]}

McMurtrie, Darren ^{[1
]}

Yang, Ju ^{[1
]}

Roth, Howard ^{[1
]}

McMahon, Jeffrey ^{[1
]}

Campbell, James J. ^{[1
]}

Ertl, Linda S. ^{[1
]}

Ong, Ryan ^{[1
]}

Wang, Yu ^{[1
]}

Zhao, Niky ^{[1
]}

Chhina, Vicky ^{[1
]}

Kumamoto, Alice ^{[1
]}

Yau, Simon ^{[1
]}

Dang, Tong ^{[1
]}

Zhang, Penglie ^{[1
]}

Schall, Thomas J. ^{[1
]}

Singh, Rajinder ^{[1
]}

机构：

[1] ChemoCentryx, Mountain View, CA USA

来源：

CANCER IMMUNOLOGY RESEARCH | 2020年 / 8卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B26

引用

页码：95 / 95

页数：1

共 50 条

[31] INCB090244, A POTENT SMALL MOLECULE THAT INHIBITS THE PD-L1/PD-1 AXIS AND FUNCTIONS SIMILARLY TO PD-L1 ANTIBODIES
Rios-Doria, Jonathan
Volgina, Alla
Gokhale, Prafulla
Liu, Hao
Stevens, Christina
Zolotarjova, Nina
DiMatteo, Darlise
Kapilashrami, Kanishk
Behshad, Elham
Thekkat, Pramod
Yang, Gengjie
Hall, Leslie
Kanellopoulou, Chrysi
Rupar, Mark
Maddage, Christopher
Horsey, April
Burke, Krista
Yang, Yan-ou
Covington, Maryanne
Wang, Steve
Liu, Phillip
Wynn, Richard
Reardon, David
Koblish, Holly
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A247 - A247
[32] Novel small-molecule antagonists of the PD-1/PD-L1 axis that mediate cell surface PD-L1 dimerization and internalization
Liu, Phillip C. C.
Wynn, Richard
Wu, Liangxing
Volgina, Alla
Zolotarjova, Nina
Lin, Luping
Thekkat, Pramod
Margulis, Alex
Klabe, Ronald
Yao, Wenqing
Xiao, Kaijiong
Li, Jingwei
He, Xin
Rupar, Mark
Chang, Hong
Waeltz, Paul
Li, Yanlong
Scherle, Peggy
Huber, Reid
Hollis, Gregory
CANCER RESEARCH, 2019, 79 (13)
[33] Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
Yan, Huiyu
Jiang, Aimin
Huang, Yinong
Zhang, Jun
Yang, Wenguang
Zhang, Wei
Liu, Tianya
FRONTIERS IN IMMUNOLOGY, 2023, 14
[34] Cimetidine enhances PD-1 blockade efficacy in melanoma by regulating PD-L1 expression on tumor
Lee, B.
Kim, D.
Lee, B.
Lee, J.
Shin, K.
Kim, H.
Ko, H.
Kim, B.
Kim, M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S217 - S217
[35] Emerging PD-1/PD-L1 antagonists for the treatment of malignant melanoma
Vanella, Vito
Festino, Lucia
Vitale, Maria Grazia
Alfano, Benedetta
Ascierto, Paolo Antonio
EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (02) : 79 - 92
[36] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
Shankar, Bairavi
Naidoo, Jarushka
JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
[37] PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
Katerina Ancevski Hunter
Mark A. Socinski
Liza C. Villaruz
Molecular Diagnosis & Therapy, 2018, 22 : 1 - 10
[38] Identification of CBPA as a New Inhibitor of PD-1/PD-L1 Interaction
Wang, Fengling
Ye, Wenling
He, Yongxing
Zhong, Haiyang
Zhu, Yongchang
Han, Jianting
Gong, Xiaoqing
Tian, Yanan
Wang, Yuwei
Wang, Shuang
Ji, Shaoping
Liu, Huanxiang
Yao, Xiaojun
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
[39] Macrocyclic Peptide Inhibitor of PD-1/PD-L1 Immune Checkpoint
Magiera-Mularz, Katarzyna
Kuska, Katarzyna
Skalniak, Lukasz
Grudnik, Przemyslaw
Musielak, Bogdan
Plewka, Jacek
Kocik, Justyna
Stec, Malgorzata
Weglarczyk, Kazimierz
Sala, Dominik
Wladyka, Benedykt
Siedlar, Maciej
Holak, Tad A.
Dubin, Grzegorz
ADVANCED THERAPEUTICS, 2021, 4 (02)
[40] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
B Paiva
A Azpilikueta
N Puig
E M Ocio
R Sharma
B O Oyajobi
S Labiano
L San-Segundo
A Rodriguez
I Aires-Mejia
I Rodriguez
F Escalante
A G de Coca
A Barez
J F San Miguel
I Melero
Leukemia, 2015, 29 : 2110 - 2113

← 1 2 3 4 5 →